Drug addiction has been conceptualized as a chronically relapsing disorder of compulsive drug seeking and taking that progresses through three stages: binge/intoxication, withdrawal/negative affect, and preoccupation/ anticipation. Via these stages, drug addiction impacts multiple motivational mechanisms and can be conceptualized as a disorder that includes elements of positive reinforcement and negative reinforcement. Three key neurobiological circuits are engaged in the motivational changes driving addiction that involve dysregulation in incentive salience-reward systems, sensitization of brain stress systems, and deficits in executive function systems. Specific neurocircuitry/neurochemical elements in these structures include the basal ganglia (incentive saliencereward deficits involving dopamine), the extended amygdala (recruitment of the brain stress systems involving corticotropin releasing factor) and the orbitofrontal/ prefrontal cortex (executive function deficits involving glutamate). The combination of dysregulated incentive salience-reward function, sensitized stress systems and disrupted orbitofrontal/prefrontal executive function provides a powerful motivation for compulsive drug use and the loss of control over drug taking. Understanding the neurocircuitry neuroadaptations in the reward, stress and executive function systems will provide new insights into identifying vulnerability to addiction and novel treatments for addiction.
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Use of alcohol, tobacco, drugs and other substances has a significant impact on global health: by any measure the global burden of disease attributable to substance use is bigger than the burden attributable to any other risk factor. Alcohol and tobacco use, highly prevalent in the world population, are among the most important contributors to poor health globally. In 2012 estimated 3.3 million deaths, or 5.9% of all deaths worldwide, were attributable to alcohol consumption. The Global strategy to reduce the harmful use endorsed by the governments of all WHO Member States provides international policy framework for action at all levels.
Reducing the harmful use of alcohol is one of the 9 targets for the Global action on prevention and control of noncommunicable diseases (NCDs).
